Medtech Inc (MDTK) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Medtech Inc (MDTK)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: bob sims who wrote (13)	5/6/1999 9:22:00 AM
From: Kevin G. O'Neill	Read Replies (1) of 66

EquityNet Research Initiates Coverage On e-MedSoft.com Separately, the Company Engages Arthur Andersen LLP as Auditors biz.yahoo.com EquityNet Research, an independent research firm, today released an Equity Research Report on e-MedSoft.com, rating the company as a Speculative Buy, with a price target of $6 to $10. The Research Report anticipates quarterly compounded revenue growth of 20% over the next two years, resulting in revenues of approximately $100 million for the company's second full year of operation. The Report also notes that the company's stock appears to be undervalued, in that it is trading at 4 times projected 12 months sales, well below the 7 to 11 times projected 12 month sales that the EquityNet analyst believes to be a more appropriate valuation. [snip]

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next